Acarbose 1g 1000mg | Purity Not Available
Adooq Bioscience
Acarbose is an anti-diabetic drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes.
More Information Supplier PageAcarbose is an anti-diabetic drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes.
More Information Supplier PageAcadesine is a selective activator of AMPK in both hepatocytes and adipocytes.
More Information Supplier PageAcadesine is a selective activator of AMPK in both hepatocytes and adipocytes.
More Information Supplier PageAcadesine is a selective activator of AMPK in both hepatocytes and adipocytes.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageAC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.
More Information Supplier PageABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 – Bcl-XL interactions with pro-apoptotic proteins .
More Information Supplier Page